bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) shares shot up 2.1% during trading on Tuesday . The stock traded as high as $0.15 and last traded at $0.15. 573 shares were traded during trading, a decline of 93% from the average session volume of 8,554 shares. The stock had previously closed at $0.15.
bioAffinity Technologies Trading Up 2.1%
The firm has a fifty day moving average price of $0.15 and a 200 day moving average price of $0.31.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
See Also
- Five stocks we like better than bioAffinity Technologies
- What Are Trending Stocks? Trending Stocks Explained
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- There Are Different Types of Stock To Invest In
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- How to Use the MarketBeat Dividend Calculator
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
